Sun Pharmaceutical Industries Share Price Today - Live Blog for May 22, 2025

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.19% increase and currently trading at ₹1,722.65 per share. This upward trajectory is turning heads in the market.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.25% boost, with the current market value at ₹1,720.85 per share. This surge has not gone unnoticed by investors.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.24%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,715.95, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.40% uptick, and they are currently valued at ₹1,719.55, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.12% drop, and it's now trading at ₹1,711.65 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.10% slump and is currently trading at ₹1,713.65. While the stock maintains a PE ratio of 36.3400, the industry PE is 33.5394, raising questions about valuation.

After a -0.06% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,716.40. The stock has a PE ratio of 36.3400, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.01%, reaching the current market price of ₹1,716.70. This ascent signifies increased investor sentiment. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.02%. At this moment, it's actively trading at ₹1,717.90, presenting an enticing opportunity for those in the market.

With a remarkable 0.20% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,717.55. Notably, this stock has a Price-to-Earnings (PE) ratio of 36.3400, while the industry's PE ratio is 33.5394.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.36%, and it is currently trading at ₹1,714.10. Additionally, the stock maintains a PE ratio of 36.3400, while the industry PE is 33.5394.

With a -0.15% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,711.20. Investors should examine the factors driving this decline. The stock's PE ratio is 36.3400, whereas the industry PE ratio stands at 33.5394.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.15% uptick, and they are currently valued at ₹1,715.80, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.19% in its share price, and it currently trades at ₹1,715.65 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

With a -0.12% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,719.85. The stock is currently trading at a PE of 36.3400, while the industry PE is 33.5394, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.18%, a development that warrants careful analysis. Presently trading at ₹1,721.05, investors are assessing whether this presents an opportunity or a risk.

With a remarkable 0.12% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,724.10. Notably, this stock has a Price-to-Earnings (PE) ratio of 36.3400, while the industry's PE ratio is 33.5394.

With a remarkable 0.12% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,724.15. Notably, this stock has a Price-to-Earnings (PE) ratio of 36.3400, while the industry's PE ratio is 33.5394.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.06%, and it is currently trading at ₹1,722.00. Additionally, the stock maintains a PE ratio of 36.3400, while the industry PE is 33.5394.

With a remarkable 0.11% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,720.90. Notably, this stock has a Price-to-Earnings (PE) ratio of 36.3400, while the industry's PE ratio is 33.5394.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.29% uptick, and they are currently valued at ₹1,720.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.07%, with its current market value per share resting at ₹1,714.70. This development highlights the stock's appeal to investors.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.04% slump and is currently trading at ₹1,714.30. While the stock maintains a PE ratio of 36.3400, the industry PE is 33.5394, raising questions about valuation.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.34%, reaching a current market price of ₹1,715.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The share price of Sun Pharmaceutical Industries Ltd experienced a -1.95% slump and is currently trading at ₹1,719.75. While the stock maintains a PE ratio of 36.3400, the industry PE is 33.5394, raising questions about valuation.